The ASCO Post | DECEMBER 15, 2013
PAGE 50
Direct From ASCO Conquer Cancer Foundation– Funded Research
Investing in the Future of Oncology
continued from page 49
The Conquer Cancer Foundation provides critical funding through its Grants and Awards Program to support young investigators like those featured in the 2013 Clinical Cancer Advances report. Career development grants like the YIA, CDA, and ACRA help researchers launch successful careers, become established in the oncology community, and make discoveries that benefit patients with cancer. Clearly, the Foundation’s initial investment in these young researchers is paying dividends, as they are succeeding in their careers, making an impact on patients, and advancing the field of oncology. By donating to the Conquer Cancer Foundation, you can help fund aspiring scientists in making the next big
earlier this year in Clinical Cancer Research, in which a lower dose of a new targeted therapy still led to shrinkage of prostate cancer metastases in 82% of patients when evaluated on bone scans and 58% of patients on this dose had a reduction in the number of tumor cells circulating in their blood. In addition to these two studies, many advances highlighted in the 2013 report were led by researchers, such as Marcia Brose, MD, who have received Foundation support early in their careers. To view and download the full 2013 report, visit www.cancerprogress.net/cca or www.jco.org.
Volume 29, Issue 15
May 20, 2011
JOURNAL OF CLINICAL ONCOLOGY Official Journal of the American Society of Clinical Oncology
Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer. S.M.A. Mahmoud et al. Editorial: R. Mouawad et al Coalesced Multicentric Analysis of Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics in the International Prognostic Scoring System. J. Schanz et al Editorial: P.L. Greenberg Phase III Study of First-Line Oxaliplatin-Based Chemotherapy Plus PTK787/ZK 222584 in Patients With Metastatic Colorectal Adenocarcinoma. J.R. Hecht et al. Editorial: A.F. Sobrero et al Phase III Study of Oxaliplatin, Fluorouracil, and Leucovorin With or Without PTK787/ZK 222584 in Patients With Previously Treated Metastatic Colorectal Adenocarcinoma. E. Van Cutsem et al Editorial: A.F. Sobrero et al Phase I Dose-Escalation Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer. T.P. Boike et al Editorial: A.V. D’Amico ASCO Special Article: Provisional Clinical Opinion: EGFR Mutation Testing for Patients With Advanced NSCLC Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy. V.L. Keedy et al. Editorial: P.A. Bunn Jr et al
www.jco.org
Top 5 most-accessed Top 10 most-accessed articles recentlyinpublished articles published 2011 in in Journal of Clinical Oncology Journal of Clinical Oncology
What’s Hot in
JCO JCO.org
Marriage Is As Protective As Chemotherapy in Cancer Care by David W. Kissane
Marital Status and Survival in Patients With Cancer by Ayal A. Aizer, et al
TLAS: Randomized, Double-Blind, Placebo-Controlled, Phase A IIIB Trial Comparing Bevacizumab Therapy With or Without Erlotinib, After Completion of Chemotherapy, With Bevacizumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer by Bruce E. Johnson, et al
breakthroughs in cancer research. Visit www.conquercancerfoundation.org/ donate to make a gift today. All gifts made before December 31, 2013, will be matched dollar for dollar by Raj
Volume 7, Issue 3
May 2011
Journal of oncology Practice The Authoritative Resource for Oncology Practices
Report on the ASCO 2010 Provider-Payer Initiative Meeting By Michael N. Neuss, MD, et al Subspecialization in Community Oncology: Option or Necessity? By Dean H. Gesme, MD, et al Current Hepatitis B Screening Practices and Clinical Experience of Reactivation in Patients Undergoing Chemotherapy for Solid Tumors: A Nationwide Survey of Medical Oncologists By Fiona L. Day, FRACP, et al Barriers to Recruitment of Rural Patients in Cancer Clinical Trials By Shamsuddin Virani, MB, BS, et al Partners and Partnerships: Trends in Private Oncology Practice By Thomas A. Paivanas, MHSA
www.jop.ascopubs.org
Mantena, RPh, doubling their impact in research support. n © 2013. American Society of Clinical Oncology. All rights reserved.
Top 5 articles Top 10 most-accessed published in articlesrecently published in 2011 in Journal of Oncology Practice Journal of Clinical Oncology
What’s Hot in
JOP
JOP.ascopubs.org Improving Pediatric Hematology/Oncology Care in the Emergency Department by Jill C. Beck
The National Cancer Institute–American Society of Clinical Oncology Cancer Trial Accrual Symposium: Summary and Recommendations by Andrea M. Denicoff, et al
Effect of Medical Oncologists’ Attitudes on Accrual to Clinical Trials in a Community Setting by Carol P. Somkin, et al
Insight or Confusion: Survival After Response-Guided Neoadjuvant Chemotherapy in Breast Cancer by Melinda L. Telli
Is Physician Employment by Health Systems an Answer? by Alice G. Gosfield
Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study by Atsushi Ohtsu, et al
Using Quality Oncology Practice Initiative Metrics for Physician Incentive Compensation by Grace Makari-Judson, et al.